Benchling overview
Verdict. The most complete feature set of the ELNs we track, and the only one with a documented biological entity registry alongside plate management and its own analytics layer. Both 21 CFR Part 11 and EU Annex 11 are documented, which is rare. The trade-offs are real: cloud only, no published price at all, and reviewers repeatedly criticise navigation and bulk operations.
Last verified
At a glance
| Vendor | Benchling, Inc., San Francisco, California, United States |
|---|---|
| Deployment | cloud |
| Lab size | small, mid, enterprise |
| Pricing | Quote only. No public commercial price. Benchling states its offer spans start-ups to the largest industry leaders, and that products, add-ons, implementation, training and support can all form part of a quote. A free offering exists for some use cases, but no standard commercial trial duration is published. |
| Modules | experiment-templates, protocols, inventory, sample-management, instrument-integration, chemical-drawing, biological-registration, plate-management, data-analysis, e-signature, lims-integration, reporting, collaboration, api |
Compliance evidence
| Standard | Evidence | Note |
|---|---|---|
| 21-cfr-part-11 | Documented | Trust page describes the platform as built for compliance, with electronic signature and audit controls. source |
| eu-annex-11 | Documented | Referenced explicitly alongside 21 CFR Part 11 on the same trust page. source |
| iso-27001 | Documented | ISO 27001:2022 certification shown in the security trust centre. source |
| soc-2 | Documented | SOC 2 Type 2 attestation. source |
| gdpr | Documented | GDPR addressed in the published security overview. source |
| gamp-5 | Unknown | |
| hipaa | Unknown | |
| iso-17025 | Unknown |
Assessment by dimension
Editorial reading of documented evidence, not a hands-on test. See how we assess.
- Overall fit Strong
Explicitly positioned for life-science R&D from start-ups to the largest organisations, and the documented feature set matches that claim.
- Compliance Strong
Part 11 and Annex 11 both documented, plus ISO 27001:2022 and SOC 2 Type 2. GAMP 5 and HIPAA remain unverified.
- Deployment execution Limited
Cloud only: no public on-premise or hybrid offer found, and no generic implementation timeframe is published.
- Pricing transparency Limited
No public commercial price of any kind, and no published minimum users, setup fee or commitment.
- Usability Mixed
4.5 out of 5 on G2 across 65 reviews, but navigation and bulk operations come up repeatedly as friction.
- Support Limited
No support theme strong enough to isolate in the independent review base, so there is no signal to report.
What Benchling is
Benchling is a cloud electronic lab notebook that sits inside a wider R&D platform. The notebook itself is positioned to “capture, access, and share work with a tool designed for modern science”, and the company describes its customers as spanning biopharma, agriculture and materials. Founded in 2012 and headquartered in San Francisco, Benchling, Inc. is a Delaware corporation. We found no official source establishing a parent company, so ownership is recorded as unknown rather than inferred.
What separates Benchling from a general-purpose notebook is that biology is modelled as structured data rather than as text. Registered biological entities such as DNA and proteins, containers and samples, and plate layouts are first-class objects, which is why the same platform can carry an analytics layer over them.
Capabilities we could document
Every capability below was found documented on Benchling’s own pages: experiment and protocol templates, a reusable protocol workflow, inventory, sample and container management, instrument integration through automation schemas, chemical structure drawing, the biological entity registry, plate and well tracking, integrated analytics through Benchling Insights, electronic signatures under GxP controls, LIMS integration, reporting, external collaboration with role-based permissions, and an open documented REST API.
One gap is worth naming: we found no standalone quality management module. Validated controls exist, but if you are looking to retire a separate QMS, that is not something Benchling’s public documentation establishes.
Deployment and implementation
Benchling is cloud only. We found no current public on-premise or hybrid offer, and if your organisation requires software inside its own infrastructure, that settles the question early. Several hosting regions are available, including the United States and the EU, depending on configuration.
No generic implementation timeframe is published. We do not estimate one: implementation length for a platform of this scope depends on how much of the registry and inventory model you adopt, and any number we invented would be misleading.
Pricing
There is no published commercial price. Benchling states its range runs “from start-up innovators to the world’s largest industry leaders”, and products, add-ons, implementation, training and support can all form part of a quote. A free offering exists for some use cases, but no standard commercial trial duration is published, and no minimum user count, setup fee or annual commitment appears publicly.
This is the single biggest practical difference between Benchling and an ELN like LabArchives, which publishes per-user prices outright. It does not make Benchling expensive or cheap — it makes it impossible to budget without talking to sales.
Compliance
Benchling is one of the few ELNs where both 21 CFR Part 11 and EU Annex 11 are documented by the vendor on the same page, rather than one being claimed in passing. ISO 27001:2022 certification appears in the security trust centre, SOC 2 Type 2 attestation on the trust page, and GDPR in the published security overview.
Three frameworks stay unknown: GAMP 5, HIPAA and ISO 17025. Unknown means our research found no sufficiently direct public statement — not that the capability is absent. If any of the three is decisive for you, ask the vendor for a document and treat the answer as the evidence.
Who it’s for, and who it isn’t
Benchling fits biology R&D teams that want entities, plates and analytics in one platform, and regulated programmes that need Part 11 and Annex 11 documented rather than asserted. It suits organisations that accept a cloud-only, quote-based relationship.
It does not fit labs with an on-premise requirement, buyers who need a number before opening a conversation, or small teams wanting a light notebook — the depth that makes Benchling powerful is also what reviewers describe as hard to navigate.
Alternatives to Benchling
- Labguru: The closest on feature breadth, with plate design and a first-party LIMS, and far better independent review scores.
- SciNote: If auditable compliance evidence and an on-premise install matter more than depth of biological modelling.
- SciSure: If the software has to run inside your own infrastructure, which Benchling does not publicly offer.
- LabArchives: If a published price and a permanent free tier are needed before any vendor conversation starts.
FAQ
How much does Benchling cost?
Benchling publishes no commercial price. Pricing is quote-based, and products, add-ons, implementation, training and support can all form part of that quote. A free offering exists for some use cases, but no standard commercial trial length is published, so budgeting requires a vendor conversation.
Is Benchling 21 CFR Part 11 compliant?
Benchling documents Part 11 controls, including electronic signatures and audit trails, on its trust page, and references EU Annex 11 alongside it. As always, compliance is a property of your validated implementation and procedures, not of the software alone.
Can Benchling be installed on our own servers?
We found no public on-premise or hybrid offer. Benchling describes itself as a cloud platform, with several hosting regions including the United States and the EU depending on configuration. If on-premise is a hard requirement, this is the wrong shortlist entry.
Who owns Benchling?
We found no official source establishing a parent company controlling Benchling, so we record its owner as unknown rather than guessing. The company is a Delaware corporation and strengthened its AI work through the acquisition of the ReSync Bio and Sphinx Bio teams in 2025.
Sources
- Benchling — Terms of Service (accessed 2026-09-18)
- Benchling — About us (accessed 2026-09-18)
- Benchling — Notebook (accessed 2026-09-18)
- Benchling — Pricing (accessed 2026-09-18)
- Benchling — Trust (accessed 2026-09-18)
- Benchling security trust centre (accessed 2026-09-18)
- G2 — Benchling reviews (accessed 2026-09-18)